Dr. Roberto A. Ferro Valdes, MD
- Medicare services, 2024
- 83,299
- Medicare patients, 2024
- 527
- Part D claims, 2024
- 1,013
- Hospital affiliations
- 2
- Industry payments
- $176,484
- Practice address
- 4701 Ogletown Stanton Rd, Newark, DE 19713
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Pathology Hematology Hgcc - HOPD
Acute Care Hospital outpatient department · Newark, Delaware
Find Dr. Ferro Valdes' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Roberto A. Ferro Valdes is a hematologist and oncologist in Newark, Delaware
Dr. Ferro Valdes practices at Pathology Hematology Hgcc - HOPD in Newark, Delaware.
Dr. Ferro Valdes' NPI, 1861780108, was assigned on July 20, 2011. Dr. Ferro Valdes holds South Dakota license 11928.
- NPI
- 1861780108NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3971734088
- NPI enumeration date
- July 20, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 45
- Medical school graduation
- 2007
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Roberto A. Ferro Valdes practices at Pathology Hematology Hgcc - HOPD in Newark, Delaware
Dr. Ferro Valdes' primary practice is Pathology Hematology Hgcc - HOPD, at 4701 Ogletown Stanton Rd, Newark, DE 19713.
- Pathology Hematology Hgcc - HOPD4701 Ogletown Stanton Rd, Newark, DE 19713
Source: Dmand AI Affiliation Data
Dr. Roberto A. Ferro Valdes is affiliated with 5 sites of care and 2 medical groups
Dr. Ferro Valdes' primary practice is Pathology Hematology Hgcc - HOPD in Newark, Delaware. Dr. Ferro Valdes is also affiliated with Christiana Hospital. The medical group on file is Medical Oncology Hematology Consultants, PA. Dmand AI also links Dr. Ferro Valdes to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Ferro Valdes' employer is on file too: a hospital.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Roberto A. Ferro Valdes' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferro Valdes practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Pathology Hematology Hgcc - HOPD | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Roberto A. Ferro Valdes is one of 42 hematologists and oncologists in Delaware
Hematology and oncology is Dr. Ferro Valdes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Ferro Valdes' licenses on file in 3 states: South Dakota, Pennsylvania and South Carolina.
Specialties and state licenses
- Hematology and oncology, South DakotaPrimary
- Internal medicine, Pennsylvania
- South Carolina license
Hematologists and oncologists near Dr. Ferro Valdes
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Roberto A. Ferro Valdes billed Medicare for 83,299 services in 2024
CMS data shows 83,299 Medicare services from Dr. Ferro Valdes across 42 procedure codes in 2024, for 527 Medicare patients. Medicare paid $1,576,414 for them.
Dr. Ferro Valdes' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 27,8692024: 80,763190%
- Tests and treatments
- 2023: 1,3002024: 1,55720%
- Office and hospital visits
- 2023: 7802024: 90716%
- Other services
- 2023: 2522024: 4582%
- Surgery
- 2023: 652024: 2758%
Where Dr. Ferro Valdes' Medicare services took place, 2024
- In an office83,189100%
- In a facility1100%
Dr. Ferro Valdes compared with the Delaware median for hematologists and oncologists, 2024
- Dr. Ferro Valdes
- Delaware median
- Medicare services
- 83,299vs 810102.8 times
- Medicare patients
- 527vs 41128% above
- Part D claims
- 838vs 59641% above
Medians across 40 hematologists and oncologists in Delaware with Dmand AI profiles that report each measure.
Dr. Ferro Valdes' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Ferro Valdes?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ferro Valdes and other hematologists and oncologists in Delaware.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Roberto A. Ferro Valdes treated 527 Medicare patients in 2024, average age 75
CMS counts 527 Medicare patients who saw Dr. Ferro Valdes in 2024. The largest group is 75 to 84, with 220 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Ferro Valdes' median patient age at 70, with 55% women.
Dr. Ferro Valdes' Medicare patients by age, 2024
Dr. Ferro Valdes' Medicare patients by sex, 2024
- Women27051%
- Men25749%
Chronic conditions among Dr. Ferro Valdes' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis52%
- Diabetes38%
- Chronic kidney disease36%
- Cancer35%
- Ischemic heart disease33%
- Mood disorders32%
Share of Medicare patients with each condition. A patient can have several.
Dr. Ferro Valdes' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women55%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Roberto A. Ferro Valdes wrote 1,013 Medicare Part D claims in 2024
In 2024, Dr. Ferro Valdes wrote 1,013 Medicare Part D claims for 120 patients. 69% of them were for generic drugs. CMS names the drug for 838 of them, across 28 drugs with 11 or more claims each, at $4,272,322 in total drug cost. In 2023, CMS named 368 claims across 15 drugs.
Dr. Ferro Valdes' Part D claims by kind of drug, 2024
- Generic695 claims69%
- Brand-name318 claims31%
Dr. Ferro Valdes' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Ferro Valdes' Part D claims, 2024
- Opioids2%18 of 1,013 claims
- Antibiotics10%104 of 1,013 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3682024: 838128%
Drugs named by CMS: 28 in 2024, 15 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Roberto A. Ferro Valdes takes part in Medicare
Dr. Ferro Valdes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Roberto A. Ferro Valdes received $176,484 in industry payments from 2016 to 2025
CMS Open Payments shows 621 general payments to Dr. Ferro Valdes from 64 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $103,385.
General payments to Dr. Ferro Valdes by program year, 2016 to 2025
General payments to Dr. Ferro Valdes by kind, 2016 to 2025
- Speaker and faculty fees$98,49056%
- Consulting fees$40,95523%
- Travel and lodging$21,94412%
- Food and beverage$13,2928%
- Other$1,6971%
Companies that paid Dr. Ferro Valdes the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Roberto A. Ferro Valdes's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Roberto A. Ferro Valdes
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Roberto A. Ferro Valdes' NPI number?
Dr. Roberto A. Ferro Valdes' NPI number is 1861780108. It was assigned on July 20, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Roberto A. Ferro Valdes?
Dr. Roberto A. Ferro Valdes is a hematologist and oncologist in Newark, Delaware. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Roberto A. Ferro Valdes practice?
Dr. Ferro Valdes practices at 4701 Ogletown Stanton Rd, Newark, DE 19713. Dr. Ferro Valdes' primary practice is Pathology Hematology Hgcc - HOPD in Newark, Delaware. Dmand AI also links Dr. Ferro Valdes to 1 hospital, 2 group practices and clinics and 1 medical group.
What is Dr. Roberto A. Ferro Valdes' medical license number?
Dr. Ferro Valdes holds South Dakota license 11928, one of the licenses on file in 3 states.
Which states has Dr. Roberto A. Ferro Valdes been licensed in?
Dmand AI has state licenses on file for Dr. Ferro Valdes in South Dakota, Pennsylvania and South Carolina.
Which hospitals is Dr. Roberto A. Ferro Valdes affiliated with?
Dr. Ferro Valdes is affiliated with Christiana Hospital. Dmand AI links Dr. Ferro Valdes to 1 more hospital.
What medical group is Dr. Roberto A. Ferro Valdes part of?
Dr. Ferro Valdes is linked to Medical Oncology Hematology Consultants, PA. Dmand AI links Dr. Ferro Valdes to 1 more medical group.
Does Dr. Roberto A. Ferro Valdes accept Medicare?
Yes. CMS data shows Dr. Ferro Valdes billed Medicare for 83,299 services in 2024, and Dr. Ferro Valdes accepts Medicare assignment.
How many Medicare patients does Dr. Roberto A. Ferro Valdes see?
CMS counts 527 Medicare patients who saw Dr. Ferro Valdes in 2024, with an average age of 75.
What services does Dr. Roberto A. Ferro Valdes bill to Medicare?
In 2024, Dr. Ferro Valdes' most billed Medicare services were injected or infused drug (J9025), injected or infused drug (J9144) and injected or infused drug (J9271).
Show 3 more questionsShow fewer questions
What drugs does Dr. Roberto A. Ferro Valdes prescribe most?
In 2024 Medicare Part D data, Dr. Ferro Valdes' most prescribed drugs by claims were Acyclovir, Eliquis and Lenalidomide.
Has Dr. Roberto A. Ferro Valdes received payments from drug or device companies?
CMS Open Payments shows $176,484 in general payments to Dr. Ferro Valdes from 64 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Roberto A. Ferro Valdes been practicing?
Dr. Ferro Valdes graduated from medical school in 2007, 19 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in Delaware by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card